Leukemia & lymphoma

9.7k papers and 150.5k indexed citations i.

About

The 9.7k papers published in Leukemia & lymphoma in the last decades have received a total of 150.5k indexed citations. Papers published in Leukemia & lymphoma usually cover Hematology (4.0k papers), Pathology and Forensic Medicine (3.6k papers) and Oncology (3.2k papers) specifically the topics of Lymphoma Diagnosis and Treatment (3.5k papers), Chronic Lymphocytic Leukemia Research (2.4k papers) and Acute Myeloid Leukemia Research (2.1k papers). The most active scholars publishing in Leukemia & lymphoma are Hagop M. Kantarjian, Tadeusz Robak, Stefano Molica, Andrea Gallamini, Michel Meignan, Michael J. Keating, Benny J. Chen, Aaron Polliack, Ting‐Chao Chou and Varsha Gandhi.

In The Last Decade

Fields of papers published in Leukemia & lymphoma

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Leukemia & lymphoma. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Leukemia & lymphoma

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Leukemia & lymphoma. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Leukemia & lymphoma with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025